ARCHIVES

Two Groups Take Different Approaches To Toxicity Of Saltz Regimen In Studies

This article is from The Cancer Letter archive.

Vol. 24 No. 6 | June 29, 2001

Download PDF Visit The Full Archive

Related Articles

PDQ Out of Business Of Setting Guidelines For Cancer Screening

September 17, 1993

More Surgical Patients Die When Nurse Caseloads Rise

November 29, 2002

In Brief: Best Guess On NCI Director: Brown First Choice, Benacerraf Second; FDa On Saccharin

April 22, 1977

Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity

October 28, 2011

Hawking Hearings Turn Up Difference Between Management, Staff At FDA

November 20, 1981

Trial Tests Selenium, Vitamin E In Prostate Cancer Prevention.

July 27, 2001